Trial Profile
Effect of Influenza Vaccination Timing on Immune Response in Patients With Inflammatory Bowel Disease on Infliximab Therapy: A Randomized Equivalence Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 May 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 05 May 2016 Status changed from not yet recruiting to completed.
- 23 Aug 2012 New trial record